Galenica Aktie 36067446 / CH0360674466
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen |
10.09.2025 06:45:03
|
Launch of Galenica Diagnostics: Acquisition of Labor Team completed
Galenica AG
/ Key word(s): Takeover
Press release
Galenica has successfully completed the acquisition of Diagnostics Group GmbH (Labor Team Group including labor team w ag), one of Switzerland’s leading diagnostic service providers. The transaction was completed on 9 September 2025 with the approval of the Federal Competition Commission (COMCO) around two months after the acquisition was announced. By purchasing Labor Team, Galenica is entering the diagnostics business. Management and laboratory expertise on the Board of DirectorsIn future, Labor Team will be managed as an independent “Galenica Diagnostics” business unit in the Products & Care segment. The company will continue to operate on the market as a legally independent entity and brand. The new Board of Directors of labor team w ag brings together the management experience of the Galenica Group and specialist laboratory expertise. The current chairman of the board of directors, Ole Wiesinger, will continue to ensure stability in this role. Thomas Szuran, Chief Products & Home Care at Galenica, Julian Fiessinger, CFO of Galenica as well as Christian Rebhan, CEO Tentamus Group, and Ralph Panoff (current) are valuable additions to the board. Rahel Kubik, who has been a member of the Board of Directors to date, will be stepping down from the Board. Labor Team and Galenica would like to thank her for her dedication over the past years. The current management team of Labor Team headed by CEO Alain M. Cahen will maintain operational responsibility. Expanding the healthcare networkIn acquiring Labor Team, Galenica is adding a leading diagnostic service provider with a strong market position to its healthcare network. In addition to the existing offerings in the area of drugs and products for the physician market, it will also be possible to offer innovative laboratory services as a single provider. In the long term, Galenica is planning to develop an innovative range of selected diagnostic laboratory services within the scope of the regulatory possibilities in pharmacies. This will further strengthen healthcare provision in Switzerland. Further details: Press release dated 02 July 2025 Dates for the diary
For further information, please contact
Welcome to the Galenica network! Around 8,000 employees at Galenica work tirelessly to improve the health and well-being of the people of Switzerland every day. With its pharmacies, pharmaceutical logistics providers, products, services and home care, Galenica has a broad and successful position in the market. We are shaping the future of healthcare in collaboration with our strong partners – by drawing on the diverse skills and extensive expertise of our entire network. Our ambition is to fulfil the needs of customers and patients in the Swiss healthcare market seamlessly, efficiently and personally. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Additional information about Galenica can be found at www.galenica.com.
End of Media Release |
Language: | English |
Company: | Galenica AG |
Untermattweg 8 | |
3027 Bern | |
Switzerland | |
Phone: | +41 058 852 81 11 |
E-mail: | info@galenica.com |
Internet: | https://www.galenica.com |
ISIN: | CH0360674466 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2194402 |
End of News | EQS News Service |
|
2194402 10.09.2025 CET/CEST
Nachrichten zu Galenica AG
09:29 |
Galenica Aktie News: Galenica am Montagvormittag mit Verlusten (finanzen.ch) | |
10.10.25 |
Galenica Aktie News: Galenica büsst am Freitagnachmittag ein (finanzen.ch) | |
10.10.25 |
Galenica Aktie News: Anleger schicken Galenica am Freitagmittag auf rotes Terrain (finanzen.ch) | |
08.10.25 |
SPI-Wert Galenica-Aktie: So viel hätten Anleger an einem Galenica-Investment von vor 5 Jahren verdient (finanzen.ch) | |
01.10.25 |
SPI-Titel Galenica-Aktie: So viel Gewinn hätte eine Investition in Galenica von vor 3 Jahren abgeworfen (finanzen.ch) | |
24.09.25 |
SPI-Titel Galenica-Aktie: So viel hätten Anleger mit einem Investment in Galenica von vor einem Jahr verdient (finanzen.ch) | |
10.09.25 |
Galenica-Aktie gefragt: Übernahme von Labor Team abgeschlossen (AWP) | |
10.09.25 |
SPI-Papier Galenica-Aktie: So viel Gewinn hätte eine Galenica-Investition von vor 5 Jahren eingebracht (finanzen.ch) |
ETFs oder Dividendenaktien – welcher Weg führt langfristig zum Erfolg
In der BX Swiss Bloggerlounge am Börsentag Zürich 2025 diskutieren Helga Bächler von liebefinanzen.ch, Angela Mygind (MissFinance) und Olivia Hähnel (BX Swiss) über zwei Strategien mit dem gleichen Ziel: finanzielle Freiheit. Im Gespräch geht es um die entscheidende Frage: 👉 Ist passives Investieren mit ETFs wirklich der bessere Weg oder lohnt sich aktives Stock-Picking doch mehr?
💬 Themen im Überblick:
💡 Vor- & Nachteile von ETFs und Einzelaktien
💡 Welche Risiken Anlegerinnen und Anleger kennen sollten
💡 Wie Dividenden motivieren können
💡 Tipps für Einsteigerinnen und Einsteiger
💡 Umgang mit Rückschlägen an der Börse
👉🏽 Jetzt auch auf BXplus anmelden und von exklusiven Inhalten rund um Investment & Trading profitieren!
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Entspannungssignale von der Zollfront: SMI mit Gewinnen -- DAX erholt sich zum Wochenstart -- Börsen in China schliessen mit Verlusten - Japan im FeiertagDer heimische Aktienmarkt zeigt sich zum Start der neuen Handelswoche etwas höher. Auch am deutschen Markt sind Gewinne zu sehen. An den Börsen in China dominierten zum Wochenstart die Bären.